MicroRNA-378 inhibits cell growth and enhances l -OHP-induced apoptosis in human colorectal cancer

IUBMB Life

Volumn 66, Issue 9, 2014, Pages 645-654

  Wang, Kai Yu ^a,b   Ma, Jun ^b   Zhang, Fu Xi ^b   Yu, Ming Jun ^b   Xue, Ji Shan ^c   Zhao, Ji Sheng ^a  

^a CHINA JAPAN UNION HOSPITAL OF JILIN UNIVERSITY   (China)

^b BEIHUA UNIVERSITY   (China)

^c GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

Author keywords

CDC40; chemoresistance; colorectal cancer; microRNA; miR 378

Indexed keywords

CISPLATIN; MICRORNA; MICRORNA 378; OXALIPLATIN; UNCLASSIFIED DRUG; CDC40 PROTEIN, HUMAN; CELL CYCLE PROTEIN; LUCIFERASE; MIRN378 MICRORNA, HUMAN; PLATINUM COMPLEX; RNA BINDING PROTEIN; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE; TUMOR MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE PROGRESSION; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUCIFERASE ASSAY; MOUSE; NONHUMAN; RNA SPLICING; TUMOR XENOGRAFT; BIOLOGY; BLOOD; CELL CYCLE CHECKPOINT; COLORECTAL TUMOR; DRUG EFFECTS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; METABOLISM; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL LINE; TUNEL ASSAY; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE CHECKPOINTS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; COMPUTATIONAL BIOLOGY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; KAPLAN-MEIER ESTIMATE; LUCIFERASES; MICRORNAS; ORGANOPLATINUM COMPOUNDS; REAL-TIME POLYMERASE CHAIN REACTION; RNA-BINDING PROTEINS; TETRAZOLIUM SALTS; THIAZOLES; TUMOR MARKERS, BIOLOGICAL;

EID: 84923107158     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.1317     Document Type: Article

References (24)

1. Jemal, A., Siegel, R., Xu, J., and, Ward, E., (2010) Cancer statistics, 2010. CA Cancer J. Clin. 60, 277-300.
2. Calin, G. A., and, Croce, C. M., (2006) MicroRNA signatures in human cancers. Nat. Rev. Cancer 6, 857-866.
3. Esquela-Kerscher, A., and, Slack, F. J., (2006) OncomiRs-microRNAs with a role in cancer. Nat. Rev. Cancer 6, 259-269.
4. Croce, C. M., and, Calin, G. A., (2005) miRNAs, cancer, and stem cell division. Cell 122, 6-7.
5. He, L., and, Hannon, G. J., (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 5, 522-531.
6. Slaby, O., Svoboda, M., Fabian, P., Smerdova, T., Knoflickova, D., et al. (2007) Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology (Basel) 72, 397-402.
7. Dassow, H., and, Aigner, A., (2013) MicroRNAs (miRNAs) in colorectal cancer: from aberrant expression towards therapy. Curr. Pharm. Des. 19, 1242-1252.
8. Ma, Y. M., Li, W. W., and, Wang, H. Y., (2013) Roles of miRNA in the initiation and development of colorectal carcinoma. Curr. Pharm. Des. 19, 1253-1261.
9. Pizzini, S., Bisognin, A., Mandruzzato, S., Biasiolo, M., Facciolli, A., et al. (2013) Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis. BMC Genomics 14, 589.
10. Zhang, J., Zhang, K. J., Bi, M. S., Jiao, X. L., Zhang, D. L., et al. (2014) Circulating microRNA expressions in colorectal cancer as predictors of response to chemotherapy. Anticancer Drugs 25, 346-352.
11. Bandres, E., Cubedo, E., Agirre, X., Malumbres, R., Zarate, R., et al. (2006) Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol. Cancer 5, 29.
12. Cummins, J. M., He, Y. P., Leary, R. J., Pagliarini, R., Diaz, L. A., et al. (2006) The colorectal microRNAome. Proc. Natl. Acad. Sci. USA 103, 3687-3692.
13. Vilar, E., Tabernero, J., and, Gruber, S. B., (2011) Micromanaging the classification of colon cancer: the role of the microRNAome. Clin. Cancer Res. 17, 7207-7209.
14. Scapoli, L., Palmieri, A., Lo Muzio, L., Pezzetti, F., Rubini, C., et al. (2010) MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression. Int. J. Immunopathol. Pharmacol. 23, 1229-1234.
15. Deng, H. X., Guo, Y. N., Song, H. J., Xiao, B. X., Sun, W. L., et al. (2013) MicroRNA-195 and microRNA-378 mediate tumor growth suppression by epigenetical regulation in gastric cancer. Gene 518, 351-359.
16. Lee, D. Y., Deng, Z. Q., Wang, C. H., and, Yang, B. B., (2007) MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. Proc. Natl. Acad. Sci. USA 104, 20350-20355.
17. Eichner, L. J., Perry, M. C., Dufour, C. R., Bertos, N., Park, M., et al. (2010) miR-378(star) mediates metabolic shift in breast cancer cells via the PGC-1 β/ERR-γ transcriptional pathway. Cell Metab. 12, 352-361.
18. Redova, M., Poprach, A., Nekvindova, J., Iliev, R., Radova, L., et al. (2012) Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma. J. Transl. Med. 10, 55.
19. Ben Yehuda, S., Dix, I., Russell, C. S., Levy, S., Beggs, J. D., et al. (1998) Identification and functional analysis of hPRP17, the human homologue of the PRP17/CDC40 yeast gene involved in splicing and cell cycle control. RNA 4, 1304-1312.
20. Dahan, O., and, Kupiec, M., (2004) The Saccharomyces cerevisiae gene CDC40/PRP17 controls cell cycle progression through splicing of the ANC1 gene. Nucleic Acids Res. 32, 2529-2540.
21. Mosakhani, N., Sarhadi, V. K., Borze, I., Karjalainen-Lindsberg, M. L., Sundstrom, J., et al. (2012) MicroRNA profiling differentiates colorectal cancer according to KRAS status. Genes Chromosomes Cancer 51, 1-9.
22. Garofalo, M., and, Croce, C. M., (2011) MicroRNAs: master regulators as potential therapeutics in cancer. Annu. Rev. Pharmacol. 51, 25-43.
23. Ben-Yehuda, S., Russell, C. S., Dix, I., Beggs, J. D., and, Kupiec, M., (2000) Extensive genetic interactions between PRP8 and PRP17/CDC40, two yeast genes involved in pre-mRNA splicing and cell cycle progression. Genetics 154, 61-71.
24. Kaplan, Y., and, Kupiec, M., (2007) A role for the yeast cell cycle/splicing factor Cdc40 in the G(1)/S transition. Curr. Genet. 51, 123-140.